Clinical significance of hepatic steatosis according to coronary plaque morphology: Assessment using controlled attenuation parameter
Journal of Gastroenterology Oct 31, 2018
Park HE, et al. - A retrospective cohort study was conducted to assess the relationship between controlled attenuation parameter (CAP)-defined nonalcoholic fatty liver disease (NAFLD) and the presence of any type of coronary plaques and various plaque compositions. The study sample consisted of seemingly healthy patients who had liver Fibroscan and coronary computed tomography at the time of health screening exams. It was noted that CAP ≥ 222 dB/m was not significant in calcified plaques, though it was significantly related to non-calcified plaque. An independent association was found between CAP-defined NAFLD and coronary plaques, particularly non-calcified plaques. Specific consideration ought to be given to the patients with NAFLD for primary prevention, given the correlation between NAFLD and non-calcified plaques.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries